INNPF
Price
$0.17
Change
+$0.09 (+112.50%)
Updated
Jul 3 closing price
Capitalization
86.96M
TSMRF
Price
$23.74
Change
-$4.41 (-15.67%)
Updated
Jun 27 closing price
Capitalization
1.44B
Interact to see
Advertisement

INNPF vs TSMRF

Header iconINNPF vs TSMRF Comparison
Open Charts INNPF vs TSMRFBanner chart's image
Innocan Pharma
Price$0.17
Change+$0.09 (+112.50%)
Volume$1.25K
Capitalization86.96M
Tsumura & Co
Price$23.74
Change-$4.41 (-15.67%)
Volume$100
Capitalization1.44B
INNPF vs TSMRF Comparison Chart in %
Loading...
INNPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INNPF vs. TSMRF commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INNPF is a Hold and TSMRF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (INNPF: $0.17 vs. TSMRF: $23.74)
Brand notoriety: INNPF and TSMRF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: INNPF: 26% vs. TSMRF: 100%
Market capitalization -- INNPF: $86.96M vs. TSMRF: $1.44B
INNPF [@Pharmaceuticals: Other] is valued at $86.96M. TSMRF’s [@Pharmaceuticals: Other] market capitalization is $1.44B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INNPF’s FA Score shows that 1 FA rating(s) are green whileTSMRF’s FA Score has 2 green FA rating(s).

  • INNPF’s FA Score: 1 green, 4 red.
  • TSMRF’s FA Score: 2 green, 3 red.
According to our system of comparison, both INNPF and TSMRF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INNPF’s TA Score shows that 3 TA indicator(s) are bullish.

  • INNPF’s TA Score: 3 bullish, 6 bearish.

Price Growth

INNPF (@Pharmaceuticals: Other) experienced а -99.05% price change this week, while TSMRF (@Pharmaceuticals: Other) price change was -15.67% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.13%. For the same industry, the average monthly price growth was +3.08%, and the average quarterly price growth was +93.03%.

Industries' Descriptions

@Pharmaceuticals: Other (+2.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TSMRF($1.44B) has a higher market cap than INNPF($87M). TSMRF YTD gains are higher at: -15.672 vs. INNPF (-99.110). TSMRF has higher annual earnings (EBITDA): 37B vs. INNPF (212M). TSMRF has more cash in the bank: 93.7B vs. INNPF (37.8M). INNPF has less debt than TSMRF: INNPF (1.46B) vs TSMRF (79.7B). TSMRF has higher revenues than INNPF: TSMRF (138B) vs INNPF (736M).
INNPFTSMRFINNPF / TSMRF
Capitalization87M1.44B6%
EBITDA212M37B1%
Gain YTD-99.110-15.672632%
P/E RatioN/A12.64-
Revenue736M138B1%
Total Cash37.8M93.7B0%
Total Debt1.46B79.7B2%
FUNDAMENTALS RATINGS
TSMRF: Fundamental Ratings
TSMRF
OUTLOOK RATING
1..100
95
VALUATION
overvalued / fair valued / undervalued
1..100
11
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
20
PRICE GROWTH RATING
1..100
84
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
30

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INNPFTSMRF
RSI
ODDS (%)
Bullish Trend 4 days ago
52%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
73%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
62%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
71%
N/A
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
9%
Advances
ODDS (%)
Bullish Trend 3 days ago
48%
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
65%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
INNPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GTLSX13.930.02
+0.14%
Glenmede Long/Short Eq Ptf Instl Shrs
PCLVX22.29N/A
N/A
PACE Large Co Value Equity P
FRLAX17.36N/A
N/A
Franklin Real Estate Securities Adv
PKSCX37.50N/A
N/A
Virtus KAR Small-Cap Core C
HBLSX14.88N/A
N/A
Hartford Balanced Income R4

INNPF and

Correlation & Price change

A.I.dvisor tells us that INNPF and HYEX have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INNPF and HYEX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INNPF
1D Price
Change %
INNPF100%
-99.04%
HYEX - INNPF
20%
Poorly correlated
N/A
APNHF - INNPF
20%
Poorly correlated
N/A
BIOVF - INNPF
20%
Poorly correlated
N/A
KKPCF - INNPF
6%
Poorly correlated
N/A
AYRWF - INNPF
6%
Poorly correlated
-4.96%
More

TSMRF and

Correlation & Price change

A.I.dvisor tells us that TSMRF and INNPF have been poorly correlated (+-0% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TSMRF and INNPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSMRF
1D Price
Change %
TSMRF100%
N/A
INNPF - TSMRF
-0%
Poorly correlated
-99.04%
TKPHF - TSMRF
-0%
Poorly correlated
N/A
TCNNF - TSMRF
-1%
Poorly correlated
+0.52%
TEVJF - TSMRF
-1%
Poorly correlated
N/A
CRYM - TSMRF
-1%
Poorly correlated
-1.43%
More